Cytokine Storm and Immunomodulation in COVID-19.
Indian J Crit Care Med
; 25(11): 1288-1291, 2021 Nov.
Article
in English
| MEDLINE | ID: covidwho-1512930
ABSTRACT
COVID-19 has become a major pandemic in recent times. The exact pathophysiology and understanding of cytokine storm and immunomodulation are evolving. Various cytokines have been implicated in the pathophysiology of COVID-19. Immunosuppressant immunomodulators like steroids, canakinumab, anakinra, tocilizumab, sarilumab, baricitinib, ruxolitinib, bevacizumab, and itolizumab have been tried. Immunostimulant immunomodulators like interferons (IFNs) and Mycobacterium w (Mw) have also been repurposed. Considering the role of multiple cytokines implicated in COVID-19, molecules working on the majority of the targets, may hold a promising future prospect. HOW TO CITE THIS ARTICLE Rangappa P. Cytokine Storm and Immunomodulation in COVID-19. Indian J Crit Care Med 2021;25(11)1288-1291.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Indian J Crit Care Med
Year:
2021
Document Type:
Article
Affiliation country:
Jp-journals-10071-24029
Similar
MEDLINE
...
LILACS
LIS